A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

There are many mechanisms at work here, but the blood sugar increase is probably secondary to the weight gain, rather than ...

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

But here’s a little insider info: Ozempic’s just the show name. The real star? Semaglutide, the active ingredient doing all ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

The intricate landscape of medical research continues to unveil groundbreaking approaches to managing chronic joint health ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.